We have computationally investigated the use of the multi-segment, multi-addition, plug-flow crystallizer (MSMA-PFC) for use in producing pharmaceutical crystals. A population balance framework was used to model the crystallization process. The dissolution of crystals can be modeled when solubility is below saturation. The evolved volume fraction distributions were optimized in a least-squares sense by manipulating a vector of decision variables in order to hit a target volume fraction distribution. The genetic algorithm was used for optimization. A reduced orthogonal array experimental design was used to examine the effect of several kinetic parameters and total crystallizer length. The results indicate that the parameters which govern nucleation are the most sensitive, followed by those for growth. Dissolution does not appreciably occur in any of the optimizations. The reason the optimization does not add any pure solvent is likely due to the addition of pure solvent causing a simultaneous decrease in concentration and decrease in residence time, which the optimization judges to be sub-optimal.
Introduction

Continuous crystallization
Continuous crystallization of pharmaceuticals has attracted much interest in recent years as a cheaper, more efficient alternative to batch-wise purification. [1] [2] [3] [4] [5] This is part of an overall much broader research effort aimed at developing fully continuous pharmaceutical manufacturing systems, including reactors, crystallizers, granulators, and tableting machines -among others. [6] [7] [8] [9] Crystallization is of special interest due to its ubiquity in pharmaceuticals -over 80% of active pharmaceutical ingredients (API) are purified by crystallization. 10 The process is widely used in the agrochemical and fine chemicals industries as well.
11,12
Motivation for In-Situ Removal of Fine Crystals
While purification is the main motive behind crystallization, the crystal size distribution (CSD) affects downstream operations and the ameliorative properties of the final dosage form. The curative properties of the final dosage form are dependent on the dissolution rate and bioavailability, which are strongly affected by the CSD and other particle properties. 13, 14 Downstream processes affected by CSD shape include filtering, washing, and drying. 15 The presence of fine crystals greatly encumbers these operations.
The typical method of removing fines is to classify the product crystals, re-dissolve the fines, separate the antisolvent when feasible, and recycle the mixture back to the crystallization system.
However, this method is problematic. Classification, recycle, and stream separation require further process equipment, increasing capital and operating costs. Classification combined with recycle has been mathematically deduced (and subsequently observed) to impart oscillatory dynamics to the CSD 12 . These oscillations make it difficult to obtain a consistent product.
Furthermore, from a risk analysis viewpoint, extra equipment is generally "more things that can go wrong", and presents another route by which microbes could contaminate the manufacturing process. It would be good if we could eliminate fines altogether by an in-situ approach.
Prior Work on In-Situ Fines Removal
Previous work by Abu Bakar et al. and Majumder and Nagy explored the concept of "in-situ" fines removal, where the operation of the crystallizer actively eliminates fine crystals during the crystallization by means of dissolution. 13, 16 With this approach, classification, re-dissolving, and stream separation are rendered (in theory) unnecessary. The work by Majumder and Nagy most closely follows our work here. 16 In that work, a constrained nonlinear optimization problem was solved to identify temperature profiles that would match a target distribution in a least-squares sense by removing fine crystals.
Cooling Crystallization versus Antisolvent Crystallization: The Coupling of Antisolvent Addition with Concentration and with Residence Time
Majumder and Nagy previously investigated computationally the use of a multi-segment cooling crystallizer for in-situ fines dissolution. 16 In that work, the decision variables were the jacket temperatures in each segment, which allowed the particular segment to go above or below solubility as necessary to dissolve the fine crystals and grow large ones. Ridder et al. have modeled and optimized a multi-segment antisolvent crystallizer for drug crystal production, but that work did not allow for dissolution to occur. 17, 18 This work is an extension of the previous works by Ridder et. al. and Majumder and Nagy, as we are now using an antisolvent crystallization with the capability to dissolve crystals when below solubility. 16 In the antisolvent case however, the addition of solvent reduces the current concentration via dilution. Also, residence time decreases monotonically with each successive segment. As we shall see further ahead, this coupling dramatically increases the difficulty of optimization and the performance of the crystallizer. antisolvent crystallization. The cooling crystallization has no coupling between residence time and the control (jacket temperature), and residence time is constant within each segment. None of this is true in antisolvent crystallization, since the addition of antisolvent simultaneously affects the current concentration via dilution, and reduces the current residence time due to a mass balance argument.
Parametric Study via Optimization of the Antisolvent Crystallizer
In this work, we present results for the steady-state operation of a multi-segment, multi-addition, plug-flow crystallizer MSMA-PFC which utilizes dissolution to eliminate fine crystals. We have explored the geometric design parameters of the crystallizer, as well as the kinetic parameters of crystallization. To reiterate, this work is an extension of that by Majumder and Nagy, but for the case of antisolvent crystallization as opposed to a cooling crystallization. flowing at flowrate (ml/min) and pure solvent at flowrate (ml/min), mixes together with the main stream for = 1,2, … , . It is to be noted that we are using mass-intensive units for our state variables, (# of crystals/kg of solution•m) and (kg API/kg solution).
Summation Indices and Segment Indices
Summation indices always use the letter as a dummy index. The letter always refers to "for the ℎ PFC segment." When an index refers to a mixing point, always refers to the mixing point immediately preceeding the ℎ PFC segment (e.g. the = 1 mixing point is the very first mixing point on the left hand side in Figure 2 above).
Effect of Dilution
The addition of streams and to the process causes a decrease in and in the oncoming feed stream due to the effect of dilution. Concentration and number density are reduced because the solute mass (and crystal mass) has remained the same, but total volume has increased. There is a double meaning of this term in the literature, as some authors refer to antisolvent crystallization as "dilution." 12 We reiterate that in this paper, we refer to dilution as being the reduction in solute concentration due to the addition of a solute-free liquid at a constant solute mass. To account for this effect, the number density of the ℎ outgoing stream, (# of crystals/kg of solution•m) about the j th mixing point is multiplied by:
Where is the density of the solution, and is the volumetric flow rate of the entire stream. can be determined by dividing the total solution mass flow rate by the total solution density:
Where 2 After mixing with the solvent and antisolvent streams, the mixture then flows into the ℎ PFC segment, where nucleation and growth occur. We assume the streams mix on a time scale well below the induction time, and also attain plug-flow. At the exit of the segment, a new size distribution, ( , ), and a reduced solute concentration, ( ), are obtained. We will abbreviate these quantities as and
. We clarify to the reader that this is not the same as +1 or +1 ; these quantities are created when the next solvent and antisolvent streams are added; the pattern of indexing is made clear in Figure 2 above. This process continues recursively until the product stream leaves the final, ℎ segment (product stream). The final crystal size distribution, , is used for solving the least-squares optimization problem. Both and are used to calculate several constraints.
Crystal Population and Solute Mass Balance Equations
Simulation of isothermal antisolvent crystallization processes requires two governing equations to be solved simultaneously: the population balance equation, and the mass balance equation.
Population Balance Equation
Population balances are a mathematical framework for tracking the properties of large populations of entities. Such balances are routinely used in the modeling of crystallization processes for the purpose of tracking size (though other properties, such as composition and shape, can also be plausibly tracked in this way).The first is the population balance equation for solving for the crystal size distribution: mathematically describes the assumption that nucleated crystals come into existence with size the control volume, while is the "external coordinate", since it is a location in physical space within the control volume. We have assumed simple one-dimensional flow in our pipe, hence why there is only one external coordinate. We believe the assumption of 1-D flow to be valid,
given that the Reynolds number for the flows studies was typically in excess of 9000. The subscript always refers to the value of a quantity in the ℎ PFC segment.
The average velocity in the x-direction in the ℎ segment is computed by dividing volumetric flow rate by the cross-sectional tube area:
Where is the inner diameter of the crystallizer tube, which is the same for all segments.
Definition of Moment
The ℎ -moment of the crystal size distribution in the ℎ PFC segment is defined by:
With units of (m k /kg solution). The interpretation of the first several moments (per kg solution)
are:
The total number of crystals.
Measure of the total end-to-end-length of the crystals.
Measure of the total interfacial surface area of the crystals exposed to the solution.
Measure of the total volume of the crystals.
Mass Balance Equation
The other equation is the mass balance for dissolved drug:
The term 2 is the second moment of the crystal size distribution (m 2 of crystals/kg solution).
is the solute concentration in the liquid phase (kg API/kg solution), is the density of crystalline API (assumed to be 1490 kg/m 3 ), 0 is the minimum detectable crystal size (m), 0 is the nucleation rate (# of nucleated crystals/kg solution•s), and is the dimensionless crystal shape factor ( /6 for spheres) 19 . In a pure mathematical treatment, 0 would simply be set to zero; however, all instrumentation used in practice for experimentation and process control will have limits to observability. Equation (6) is an integro-differential equation, since 2 is defined by the integral expression (5).
Boundary Conditions
For the first segment ( = 1), the boundary conditions for these equations are:
Where 0 is the crystal size distribution of the seed crystals, 0 is the nucleation rate (#/kg of solution•s), and 0 is the initial solute concentration. In subsequent segments ( ≥ 2), the boundary conditions become:
A Gaussian bell curve was used for 0 (#/kg of solution•m) in all cases, with mean (m) and standard deviation (m):
Where is the total number density (# of crystals/kg solution). can be interpreted in (9) as a constant that forces the seed distribution to agree with the specified seed mass loading, (%, dimensionless). The mass balance on the seed distribution is closed by solving the algebraic equation for such that:
where 3,0 is the third moment of the seed distribution. Equation (10) is closed by manipulating , which is embedded in the integral term 3,0 :
Growth, Nucleation, and Dissolution Rate Laws
The growth and nucleation laws are given by the equations (again, all subscripts refer to the ℎ segment):
where is the supersaturation ratio, is the growth rate constant (m/s), is the growth rate order, is the nucleation rate constant, is the nucleation order, is the dissolution rate (m/s), is the dissolution order, and is the solubility concentration (kg API/kg solution). is replaced by in (3) for < 1.
We use a modified version of the growth law for the dissolution rate law. The dissolution rate can be approximated by multiplying the modified version of the growth law by a constant > 1, which adjusts for the fact that dissolution is typically much faster than growth. The calculation of is discussed in section 3.6 below. The values of the kinetic parameters are taken from experimental work by Luo et al. and are included in Table 1 . 19 These parameters were chosen because they are expressed in terms of water mass fraction, which is significantly easier to work with than other representations. 
Calculation of API Solubility
The solubility of the API in a water-ethanol (solvent-antisolvent) mixture at 25 ℃ was taken from the experimental data plot provided in Figure 2 of Luo et al. 19 for the case of the drug biapenem. Data points were extracted from the curve, and are given in The water mass fraction in the ℎ PFC is computed by:
Plugging 2 into the curve fit object created in MATLAB yields the solubility concentration of biapenem, , .
Solution of Model Equations
A typical method used for solving equations (3) and (6) is to apply the method of moments (MOM), which reduces system to a small number of coupled ordinary differential equations for the moments of the crystal size distribution. However, this method is useless here, since we need the full CSD to be able to match the target distribution. Previous researchers have attempted various deconvolution/inversion methods in the moments to re-construct the crystal size distribution, but these methods tend to yield poor results and be more trouble than they are worth. 20 A variety of methods have been developed for direct solution of the population balance equation. To solve this system, we have utilized a high-resolution finite volume (FV) technique, which is the combination of the semi-discrete FV technique with the van Leer flux limiter. 16, 21 This method provides (ℎ 2 ) accuracy where the solution is smooth, without the oscillations found in other methods. Details on the finite volume method are given in Majumder and Nagy.
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Equation (3) was discretized into ordinary differential equations, where is the number of crystal size bins. The discretization started at 1 μm, and marched upward up to the maximum bin size of 500 μm, for a total of = 101 bins. Equations (3) and (6) are solved simultaneously, with the sixth-order accurate Boole's Rule used to approximate 2 in (6). The method marches forward into external space, using 10 steps in external space.
Optimization Problem Formulation
Our goal is to eliminate the production of fine crystals by utilizing dissolution. The quality of the elimination is ascertained by measuring how closely the attained volume fraction distribution leaving the ℎ PFC ( , , ) matches a theoretically-best growth-only volume fraction distribution, , . The target distribution is generated by simulating the crystallization with only one segment, with nucleation arbitrarily set to zero. With no nucleation, all solute depletion is solely due to crystal growth on the seeds, and no fine crystals are ever created. Thus, the target distribution is a hypothetical best-case scenario of pure growth achieved without nucleation. The closeness of matching can be expressed in a least-squares sense. By manipulation of the antisolvent and solvent flowrates in each segment (and other decision variables), we can make the fit between the model and the target distribution tighter.
Equations (3) and (6) 
Least-Squares Objective Function
The final volume fraction distribution, , , , is used for formulating the least-squares problem:
. . Model equations 3 − 13 constraints (discussed later)
Where is the vector of 2 + 5 decision variables, and , , is the volume fraction size distribution at the exit of the crystallizer. It is computed as:
The index in (14) refers to a particular crystal size bin, with total bins. Note that integrates to (the total number of crystals in the solution), while , , integrates to 1. We use the volume fraction distribution instead of the number density, since the addition of extra solvent and antisolvent causes dilution.
List of Decision Variables and Bound Constraints
All 2 + 5 decision variables in these optimizations had bound constraints. Table 3 below summarizes the decision variables and their lower/upper bounds. The optimization of the MSMA-PFC is known to be highly non-convex, as shown by the landscape plots in Ridder et al. 17 Such problems are not amenable to gradient search, and so we have opted for a stochastic approach to circumvent the nonconvexity. The genetic algorithm (GA) is a popular tool for solving optimization problems with this kind of difficulty. To make the GA operate more smoothly, our decision variables were fractions of the total antisolvent and total pure solvent. The flowrate into a segment is the ℎ fractional distribution variable multiplied by total flow allotment.
Linear and Nonlinear Constraints
There were no linear inequalities in this study. The only linear constraints in this work are two equalities, which require the apportionments of total liquid flows must each sum to unity. The remaining four constraints are nonlinear inequalities. Table 4 below summarizes these constraints. In the multiple-cooling segment PFC array, residence time is constant, since flowrate of liquor into each segment is always the same. However, the addition of antisolvent and pure solvent to the liquor flow changes residence time into a nonlinear function:
Where / is the length of a single segment. The ℎ summand in (17) is the residence time for the ℎ segment, which is the segment's volume divided by the total flow rate through that segment. The total residence time is found by summing over all individual residence times.
Since each PFC segment's volume is the same, it is taken out of the summation distributively.
Yield is calculated in the following manner:
If
= 0, then all of the solute has been crystallized, and thus = 1. If no crystallization has occurred, the numerator will be zero, and thus = 0. If seed crystals have been dissolved due to excessive dissolution, then can become negative.
Solution of Least-Squares Problem by the Genetic Algorithm
Nonconvexity of Search Space
The genetic algorithm is an optimization algorithm based on the theory of natural selection.
Briefly, solutions to the optimization problem are filtered by starting with a large initial "population", and judging their "fitness" in terms of the score they output when substituted into the objective function. "Unfit" candidates are eliminated from the gene pool, while the survivors have "children" with each other by various genetic operators of crossover and mutation. This process repeats itself for several "generations" or until a certain tolerance threshold on the objective function is satisfied. More complexity arises when constraints are introduced into the problem. The GA is less efficient compared to gradient-based methods, such as sequential quadratic programming (SQP). However, algorithms like SQP are not robust to initial guess, and can become trapped in a sub-optimal local minimum. 22, 23 This is true when the objective function and/or constraints are non-convex. Stochastic methods, such as the GA or simulated annealing, are appropriate for nonconvex optimization.
Genetic Algorithm Solution
The problem was solved by manipulating the 2 + 5 decision variables with the genetic algorithm (GA). The initial population was created by randomly sampling over the bounds given in Table 3 . The number of injections was arrived at through trial and error. The number of injections could not be used as a decision variable, as MATLAB's current genetic algorithm cannot solve mixed-integer nonlinear programming (MINLP) problems that have any type of equality constraint. The number of injections used was 50, which gave a good tradeoff between curve fit and computation time. The population size was 750, repeated for up to 25 generations.
The MATLAB integrator, depending on the particular run, was chosen for the quickest solution time. Either ode45, ode15s, or ode23 were used.
Results and Discussion
To investigate the crystallizer's performance for various kinetic parameters and total lengths, a reduced orthogonal array experimental design was used, with five factors, four levels, and 16 total runs. The five factors are the nucleation and growth parameters, and the total crystallizer length. The five factors and the four levels used are shown in Table 5 below. Table 5 . The sum of the squares of the errors (SSE) and total amount of pure solvent added ( ) are given for each run. Table 6 above shows the experimental design matrix, as well as the resulting sum of the squared errors for each curve fit to the zero-nucleation target distribution.
The numbers correspond to the level column in
Volume Fraction Distributions for Optimized Cases
The data in Table 6 show that run #1 gave the tightest curve fit (Figure 4 ). The reason for this tight curve fit is due to the system exhibiting low nucleation (the level is at the lowest level).
Also in Figure 4 . we show the performance of a single segment with nucleation turned back on ( 0 > 0). We can see there is little improvement observed between MSMA-PFC and using a single segment. Increasing values of rapidly degrade the curve fit due to overwhelming nucleation. Run #11 is representative of runs which are nucleation-dominated. As shown in Figure 5 , there is a large amount of fines created, and the optimal result fails to hit the target distribution. While we have improved the volume fraction distribution over the single-segment case by producing less fines at the exit, there is still a great deal of fines produced. The nucleation rate constant has the greatest effect upon the performance of the crystallizer, indicating significant sensitivity to nucleation rate. 
Main-Factor Analysis
The results in section 6.1 suggest to us that the best results, intuitively, are obtained when the system is growth-dominated. Main-factor analysis of the experimental matrix confirms this suspicion. Main-factor analysis is done by taking the average of all SSE for a given factor at the same level. For example, the average for the factor at level 2 would take the average SSE over runs 5, 6, 7, and 8. This process is repeated for all five factors and all four levels, which generates Table 7 below. This analysis reveals to us what the most sensitive parameters are, and also what set of levels will provide the best curve fit -which we hypothesized would be the growth-dominated case.
We can see in Table 7 that the factor spans the widest range of SSE values over the level averages. We thus conclude that is the most sensitive parameter. Following the same line of reasoning, the second-most sensitive parameter is . The optimal curve fit is projected to be the set of levels for which SSE is a minimum for each corresponding factor. These values are shown in boldface in Table 7 (they are the minimum values within each column). The main-factor analysis projects that the tightest curve fit will be observed at a of level 1, a of level 1, a of level 4, a of level 2, and an of level 3. We term this the "projected optimum." Note that this set of factors and levels is not present in Table 6 . Solving the optimization problem with this new set of parameters generates the volume fraction distributions in Figure 6 , which had an SSE of 4.83 × 10 5 , which is less than the minimum of 7.58 × 10 5 in Table 6 . This result matches our intuition that the best result is obtained when nucleation is slow and growth is fast. However, this has the effect of "cancelling out" the benefits of using multiple injections, as we obtain a very tight fit to the curve anyways when using a single injection for this set of kinetic parameters. There was no discernible trend observed with respect to the optimized tube diameter. However, seed loading was typically between 5.0%-6.5%.
No Dissolution is Used to Control Fines
It is interesting (even if a bit disappointing) to observe that the optimization does not want to use dissolution to get rid of fine crystals. The total amount of pure solvent added during each optimization is given as the rightmost column in Table 6 . Observe that little to no pure solvent is ever added to the system for the optimal curve fits (observe in Table 3 that is bounded on the left by zero). The supersaturation ratio profiles ( vs. plots) show barely any dissolution occurring. The supersaturation profile for the "project optimum" is representative (Figure 7 ). Note how the supersaturation does not significantly (or at all) go below 1 anywhere in Figure 7 .
This indicates to us that the situations in which the curve fit is superior to the single-segment case ( Figure 4 and Figure 5 ) is more likely due to the better control offered by using multiple segments (and thus having finer control over supersaturation), rather than making use of fines dissolution. The reason the optimization refuses to add pure solvent in significant amounts is due to the fact that adding pure solvent reduces the concentration (via dilution) and reduces available residence time (via equation (17)). Reduced concentration reduces the available supersaturation, and reducing the residence time reduces the time available for growth inside the MSMA-PFC.
Thus, despite the potential for dissolving fines, the benefit of adding pure solvent does not counterbalance the other two negative phenomena.
Summary and Conclusions
We have investigated the optimal operation of antisolvent crystallization in a MSMA-PFC and The results indicate that is the most sensitive parameter, followed by . As increases, the curve fit degrades rapidly due to becoming overwhelmed by nucleation.
Examination of the supersaturation profiles shows that dissolution is not occurring appreciably for any of the optimizations performed. The MSMA-PFC performs best under kinetic crystallization conditions in which a single PFC also works sufficiently well. There are situations where using multiple additions does improve the curve fit versus the single-segment case, but excessive fines still exist. The reason the optimization does not add any pure solvent is likely due to the addition of pure solvent causing a simultaneous decrease in concentration and decrease in residence time. Both of these cause the optimization to take "one step forward and two steps back", thus adding pure solvent is judged to be sub-optimal.
To implement this system in practice, several sensors and control loops would be necessary. A variety of low-cost sensors have been developed in recent years. 24 The paper by Some comparison with the previous work by Majumder and Nagy is in order. 16 That work is very similar to this work. In both cases, crystallization is being optimized in a leastsquares sense by manipulating process parameters in order to hit a target distribution. In that work however, temperature was the method for altering supersaturation, whereas in this case we used antisolvent to alter liquid-phase composition (and hence, the supersaturation). One of the key differences between that work and this work, is that temperature cycling is observed to be the optimal strategy for the elimination of fine crystals. It was observed in that work further that the efficacy of the optimization was significantly enhanced if the crystallization and dissolution kinetics were size-dependent. We have not considered size-dependency in this work, which may be a worthwhile subject of future investigation. 
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